A Study to Learn More About How Well Aficamten Works in Japanese Participants With Symptomatic Obstructive Hypertrophic Cardiomyopathy
NCT07023341
·
clinicaltrials.gov ↗
PHASE3
Phase
ACTIVE_NOT_RECRUITING
Status
36
Enrollment
INDUSTRY
Sponsor class
Conditions
Obstructive Hypertrophic Cardiomyopathy
Interventions
DRUG:
BAY3723113
Sponsor
Bayer